Last $25.44 USD
Change Today +0.34 / 1.35%
Volume 416.8K
EBS On Other Exchanges
Symbol
Exchange
Berlin
New York
As of 8:04 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Steven N. Chatfield Ph.D.

Former Executive Vice President of Strategic Investments Division, Emergent BioSolutions, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

56$916,092
As of Fiscal Year 2013

Background*

Dr. Steven N. Chatfield, Steve, Ph.D. had been an Executive Vice President of Strategic Investments Division at Emergent BioSolutions, Inc. since April 2013 until March 31st 2014. Dr. Chatfield served as the President of Biosciences Division and Executive Vice President at Emergent BioSolutions, Inc. from January 2012 to April 2013. Dr. Chatfield served as Senior Vice President of Strategic Investments at Emergent BioSolutions, Inc. since March 2010 and as its Chief ...

Read Full Background

Corporate Headquarters*

2273 Research Boulevard
Rockville, Maryland 20850

United States

Phone: 301-795-1800
Fax: 301-795-1899

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
University of Birmingham

Other Affiliations*

Annual Compensation*

Salary$361,887
Bonus$185,647
Total Annual Compensation$547,534

Stock Options*

Restricted Stock Awards$175,145
All Other Compensation$45,675
Exercisable Options Value$133,447
Unexercisable Options Value$303,209
Total Value of Options$436,656

Total Compensation*

Total Annual Cash Compensation$593,209
Total Short Term Compensation$547,534
Other Long Term Compensation$220,820
Total Calculated Compensation$916,092
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EBS:US $25.44 USD +0.34

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
William S. Marth Chief Executive Officer, President, Director and Member of Audit Committee
Albany Molecular Research Inc.
--
M. Michelle Berrey M.D., MPH.Chief Executive Officer, President and Chief Medical Officer
Chimerix, Inc.
$47.7K
Franck Grimaud MBAChairman of Management Board and Chief Executive Officer
Valneva SE
€206.6K
Anders Hedegaard MScChief Executive Officer and President
Bavarian Nordic A/S
--
Anthony S. Marucci M.B.A.Chief Executive Officer, President and Director
Celldex Therapeutics, Inc.
$871.4K
Compensation as of Fiscal Year --.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EMERGENT BIOSOLUTIONS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.